Cargando…
New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon
OBJECTIVE: To propose two new indicators for monitoring access to antiretroviral treatment (ART) for human immunodeficiency virus (HIV); (i) the time from HIV seroconversion to ART initiation, and (ii) the time from ART eligibility to initiation, referred to as delay in ART initiation. To estimate v...
Autores principales: | Ndawinz, Jacques DA, Anglaret, Xavier, Delaporte, Eric, Koulla-Shiro, Sinata, Gabillard, Delphine, Minga, Albert, Costagliola, Dominique, Supervie, Virginie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581657/ https://www.ncbi.nlm.nih.gov/pubmed/26478609 http://dx.doi.org/10.2471/BLT.14.147892 |
Ejemplares similares
-
Antiretroviral Drug Resistance and Routine Therapy, Cameroon
por: Laurent, Christian, et al.
Publicado: (2006) -
Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
por: Aghokeng, Avelin F, et al.
Publicado: (2013) -
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon
por: Mbougua, Jules B Tchatchueng, et al.
Publicado: (2010) -
Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test
por: Temfack, Elvis, et al.
Publicado: (2018) -
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)